C. Marshall Paul has more than 40 years experience in the pharmaceutical and market research industry and is president of ACNielsen HCI.
Marshall Paul started his career in 1962 as a marketing analyst for Merck & Co., Inc. In 1982, Paul built a new company, HCI, Inc. In November 1997, HCI was acquired by VNU and merged with its subsidiary PERQ Research. In January 2002, Marshall Paul was appointed president of ACNielsen HCI, a new company formed to help design and market the initiatives of other VNU subsidiaries, including HCI.
C. Marshall Paul graduated from Dickinson College and has a bachelor of science degree in Economics.
If I deal with a particular therapeutic class, we mentioned before, looking at the antidepressant market, you can have Eli Lily that has Prozac. You can have SmithKline with Paxil. You can have Pfizer with Zoloft. You have Wyeth with its product Effexo...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login